TCHC is the second acquisition of Blackstone in Japan’s healthcare sector. In 2019, the private equity alternative investment management and financial services firm acquired Ayumi Pharmaceuticals.
Blackstone and Takeda are expecting to complete the transaction by end of March 2021.
————————————————–
Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.
Want guaranteed coverage? We also offer contract journalism here. Just be sure you’re comfortable giving up editorial control because our journalists are dogged and will follow the story through to the conclusion. The story will be published to our exacting standards, without regard for your preferred slant.
Want to contribute a story? We also accept article submissions — check out our writer’s guidelines here.
